Daniel J. Brennan, EVP and CFO at BOSTON SCIENTIFIC CORP (BSX), sold 166,826 shares at $105.24 ($17.5M) on 2025-02-19, disclosed to the SEC on 2025-02-19.
Scheduled sale ($17.5M) by EVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.08 | 2,900 | $302K | 1.7% |
| 2 | $104.67 | 14,630 | $1.5M | 8.7% |
| 3 | $104.67 | 14,630 | $1.5M | 8.7% |
| 4 | $105.24 | 67,333 | $7.1M | 40.4% |
| 5 | $105.24 | 67,333 | $7.1M | 40.4% |
| Total | $105.12 avg | 166,826 |
| $17.5M |
| 100% |
| Filing → |
| BSX | SELL | 2024-05-23 | $16.9M | — | Filing → |
| BSX | SELL | 2024-02-20 | $1.8M | — | Filing → |
| BSX | SELL | 2023-03-02 | $8.5M | — | Filing → |